1月21日，泰禾股份涨1.67%，成交额1.23亿元。两融数据显示，当日泰禾股份获融资买入额975.73万 元，融资偿还1452.91万元，融资净买入-477.18万元。截至1月21日，泰禾股份融资融券余额合计 7623.16万元。 融资方面，泰禾股份当日融资买入975.73万元。当前融资余额7599.82万元，占流通市值的6.39%。 截至1月9日，泰禾股份股东户数1.16万，较上期增加1.97%；人均流通股3288股，较上期减少1.93%。 2025年1月-9月，泰禾股份实现营业收入38.90亿元，同比增长28.69%；归母净利润3.67亿元，同比增长 120.56%。 分红方面，泰禾股份A股上市后累计派现2.70亿元。 机构持仓方面，截止2025年9月30日，泰禾股份十大流通股东中，香港中央结算有限公司位居第六大流 通股东，持股23.02万股，相比上期减少17.17万股。 责任编辑：小浪快报 融券方面，泰禾股份1月21日融券偿还5900.00股，融券卖出700.00股，按当日收盘价计算，卖出金额 2.18万元；融券余量7507.00股，融券余额23.33万元。 资料显示，南通泰禾化工股份有限公司位于上海 ...

Group 1 - The core viewpoint of the news is that Taihe Co., Ltd. has shown significant financial performance with a notable increase in revenue and net profit for the year 2025 [2] - As of January 19, Taihe's stock price increased by 2.01%, with a trading volume of 106 million yuan, and a net financing buy of -272,700 yuan [1] - The company has a total financing and securities balance of 81.45 million yuan, with a financing balance of 81.07 million yuan, accounting for 6.96% of the circulating market value [1] Group 2 - For the period from January to September 2025, Taihe achieved an operating income of 3.89 billion yuan, representing a year-on-year growth of 28.69%, and a net profit attributable to shareholders of 367 million yuan, reflecting a 120.56% increase [2] - The company has distributed a total of 270 million yuan in dividends since its A-share listing [3] - As of September 30, 2025, the top ten circulating shareholders of Taihe include Hong Kong Central Clearing Limited, which holds 230,200 shares, a decrease of 171,700 shares from the previous period [3]

Core Viewpoint - The article discusses the impact of the upcoming export tax rebate cancellation on various companies in the glyphosate industry, highlighting their strategies to mitigate cost pressures and capitalize on market opportunities. Group 1: Company Strategies and Advantages - Xingfa Group, a leading player in the phosphate chemical industry, benefits from a complete supply chain and cost control, allowing it to quickly pass on cost pressures post-export tax rebate cancellation [1][19] - Yangnong Chemical, a leader in the biorational pesticide sector, plans to shift towards high-value formulation exports, leveraging its strong overseas registration and channel networks [2][20] - Hebang Biotechnology has a high self-sufficiency rate in raw materials, which helps it mitigate cost increases and capture orders during overseas inventory replenishment cycles [3][19] - Runfeng Co., a prominent pesticide exporter, can quickly adjust its product structure to high-value formulations, benefiting from its global partnerships and supply chain flexibility [4][20] - Xin'an Chemical, known for its integrated production model, significantly reduces costs and enhances flexibility in price transmission through its dual production of organic silicon and glyphosate [5][21] Group 2: Market Position and Growth Potential - Taihe Co. focuses on raw material production and aims to expand its market share by optimizing production costs and enhancing its domestic formulation market presence [6][22] - Andermatt Biocontrol, a global leader in pesticide formulations, plans to leverage its strong R&D capabilities and global network to maintain market leadership post-tax rebate changes [7][24] - Lier Chemical, with a complete R&D and production system, aims to enhance its market position through technological upgrades and a stable raw material supply chain [8][25] - Nopson, a leading pesticide formulation company, is expected to strengthen its domestic market position by quickly adapting to changes in export pressures [9][26] - Jiangshan Co., a top glyphosate producer, is positioned to benefit from its scale and technological advantages, allowing it to consolidate market share amid industry restructuring [10][28] Group 3: Industry Trends and Challenges - The glyphosate industry is experiencing consolidation, with companies poised to capture market share from smaller players exiting the market due to increased competition and regulatory pressures [11][29] - Companies are focusing on technological advancements and product iterations to address challenges such as glyphosate resistance and to enhance their competitive edge [12][30] - The shift towards high-value formulations and domestic market focus is a common strategy among companies to mitigate the impact of the export tax rebate cancellation [13][34]

Core Insights - The expiration of the compound patent for Pyraclostrobin in China has led to a surge in domestic interest, with companies increasing registration, production, and promotion efforts [1][6] - As of 2024, there are 62 registered Pyraclostrobin products in China, including 32 active ingredients and 30 formulations, primarily targeting wheat and peanut crops [1][6] - The global market for Pyraclostrobin has seen significant growth, with sales expected to rise from $973 million in 2015 to $2.014 billion by 2024, and projected to reach $2.172 billion by 2025 [5][11] Industry Overview - Pyraclostrobin, developed by Bayer in 2004, is a broad-spectrum fungicide known for its low toxicity and effectiveness against various plant diseases [2][3] - It is particularly effective against diseases affecting cereals and legumes, making it a key product in the global fungicide market, holding an 8% market share [3][5] Market Dynamics - The Chinese market for Pyraclostrobin is expanding rapidly due to the high incidence of wheat diseases, particularly Fusarium head blight, which can cause yield losses of 10% to 20% in epidemic years [7][11] - The area affected by Fusarium head blight in China is projected to reach 15 million acres in 2024, an increase of 6 million acres from 2023 [7][8] Competitive Landscape - Major companies in the Pyraclostrobin sector include Hailir, Anhui Jiuyi, Nantong Taihe, and Guangdong Guokang, among others, with many expanding production capacity [9][10] - Hailir reported a revenue of 3.391 billion yuan in the first nine months of 2025, a 5.5% increase year-on-year, indicating strong market performance [10] Future Trends - The demand for Pyraclostrobin is expected to continue rising due to increasing occurrences of wheat diseases and advancements in application methods [11] - The market is becoming increasingly competitive, with potential oversupply leading to price fluctuations, necessitating companies to optimize production and enhance brand presence [12] - The trend towards formulation mixtures is anticipated to grow, as combining Pyraclostrobin with other chemicals can delay resistance development and enhance efficacy [13]

（文章来源：证券日报） 证券日报网讯 1月12日，泰禾股份在互动平台回答投资者提问时表示，截至2026年1月9日，公司股东总 户数为11632户。 ...

Group 1 - The glyphosate concept index declined by 0.02%, ranking among the top declines in the concept sector, with companies like Hebang Biotechnology, Jiangshan Shares, and Xingfa Group experiencing significant drops [1] - Among the companies in the glyphosate sector, 9 stocks saw price increases, with notable gains from Nuo Shun (up 4.20%), Li Er Chemical (up 3.45%), and Jiang Tian Chemical (up 2.26%) [1][3] Group 2 - The glyphosate concept sector experienced a net outflow of 234 million yuan, with 13 stocks seeing net outflows, and 5 stocks exceeding 10 million yuan in outflows, led by Hebang Biotechnology with a net outflow of 134 million yuan [2] - Other companies with significant net outflows include Jiangshan Shares (57.89 million yuan), Hongtaiyang (29.72 million yuan), and Xin'an Shares (23.04 million yuan) [2] - Conversely, the companies with the highest net inflows included Li Er Chemical (40.21 million yuan), Nuo Shun (18.77 million yuan), and Zhongnong Lihua (3.39 million yuan) [2]

Core Insights - The launch of the new insecticide "Haode Gelaiya®" (10% Cypermethrin dispersible liquid) marks a significant step for Taihe Co., showcasing its commitment to innovation and technology in the agricultural sector [1][10] - Taihe Co. aims to transition from a focus on imitation to creation, emphasizing the importance of technological innovation in overcoming industry challenges and enhancing competitiveness on a global scale [3][14] Company Overview - Taihe Co. is positioned as a global technology-driven enterprise, leveraging 363 patents and four production bases to maintain a leading edge in core products like Azoxystrobin and 2,4-D [1][10] - The company has established a comprehensive innovation platform from molecular design to commercialization, utilizing AI-assisted design and market-driven mechanisms [1][10] Product Details - "Haode Gelaiya®" is recognized as an IRAC Group 30 product, focusing on addressing resistance issues in Lepidoptera pests, and has been granted 67 patents [1][10] - The product demonstrates significant efficacy against pests such as Plutella xylostella and Spodoptera exigua, with rapid action and environmental safety [8][19] Industry Context - The introduction of "Haode Gelaiya®" is seen as a benchmark in the agricultural sector, representing a strategic shift towards innovation amidst industry challenges [5][14] - The Chinese Pesticide Industry Association emphasizes the need for the industry to move away from price wars and towards high-quality development driven by technological innovation [5][14] Strategic Goals - Haode Co. has set clear development objectives, focusing on key crops like wheat and corn, with plans to cover 3 million acres within three years through innovative product offerings [6][14] - The company aims to build strong partnerships and a stable network to foster a collaborative and successful business environment [6][14]

Group 1 - The glyphosate concept sector declined by 0.44%, ranking among the top declines in the concept sector, with major declines seen in companies like Xin'an Chemical, Lier Chemical, and Jiangshan Chemical [1] - Among the companies in the glyphosate sector, eight stocks saw price increases, with Jiangtian Chemical, Taihe Co., and Nuofengxin leading the gains at 0.58%, 0.52%, and 0.46% respectively [1] - The main capital outflow from the glyphosate sector today was 146 million yuan, with 14 stocks experiencing net outflows, and six stocks seeing outflows exceeding 10 million yuan [1] Group 2 - Xin'an Chemical had the highest net capital outflow of 51.38 million yuan, followed by Nuofengxin, Xingfa Group, and Runfeng Co. with outflows of 19.73 million yuan, 14.59 million yuan, and 12.70 million yuan respectively [1] - The stocks with the highest net capital inflow included Yangnong Chemical and Ando Mai A, with inflows of 0.67 million yuan and 0.06 million yuan respectively [2] - The trading volume for Xin'an Chemical was 3.74%, while Lier Chemical had a turnover rate of 4.12% [1][2]

Core Viewpoint - Taihe Co., Ltd. (301665) reported that as of December 31, 2025, the total number of shareholders is 11,407 [1] Summary by Category - Company Information - Taihe Co., Ltd. has a total of 11,407 shareholders as of the specified date [1]

Group 1 - The company, Taihe Co., Ltd. (301665.SZ), currently has no plans for share repurchase [1]